The facility in Kabul, Afghanistan, is emerging as a important contributor in the global supply market for Abacavir Sulphate API. This regional manufacturing capacity represents a notable step beyond for the Afghan pharmaceutical sector and offers a distinct opportunity to decrease requirement on